PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNPSN.L Regulatory News (NPSN)

  • There is currently no data for NPSN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

8 Jun 2021 16:50

RNS Number : 2091B
Prosus NV
08 June 2021
 

Prosus N.V.

(Incorporated in the Netherlands)

(Legal Entity Identifier: 635400Z5LQ5F9OLVT688)

AEX and JSE Share Code: PRX ISIN: NL0013654783

(Prosus)

 

Update on NASPERS SHARE PURCHASE

Prosus today announces an update to its share purchase programme of Naspers N ordinary shares (the Share Purchase) announced on 23 November 2020.

 

Although there is no regulatory requirement to do so, Prosus decided to continue providing weekly voluntary updates on the Naspers N ordinary shares purchased. For the period between 31 May 2021 and 4 June 2021, Prosus purchased 440 880 Naspers N ordinary shares at an average price of ZAR3 057.8213 per share for a total consideration of ZAR1 348 132 268.64 (US$98 629 853.26).

More information on the Share Purchase is available on www.prosus.com/investors/share-buyback.

Amsterdam, the Netherlands

8 June 2021

JSE sponsor to Prosus

Investec Bank Limited

 

 

Enquiries

Investor Enquiries

Eoin Ryan, Head of Investor Relations

+1 347-210-4305

Media Enquiries

Sarah Ryan, International Media Relations

+ 31 6 29721038

About Prosus

Prosus is a global consumer internet group and one of the largest technology investors in the world. Operating and investing globally in markets with long-term growth potential, Prosus builds leading consumer internet companies that empower people and enrich communities.

 

The group is focused on building meaningful businesses in the online classifieds, food delivery, and payments and fintech sectors in markets including India, Russia and Brazil. Through its ventures team, Prosus invests in areas including edtech and health, Prosus actively seeks new opportunities to partner with exceptional entrepreneurs who are using technology to improve people's daily lives.

 

Every day, millions of people use the products and services of companies that Prosus has invested in, acquired or built, including Avito, Brainly, BYJU'S, Bykea, Codecademy, DappRadar, dott, ElasticRun, eMAG, Eruditus, Honor, iFood, Klar, LazyPay, letgo, Meesho, Movile, OLX, PayU, Red Dot Payment, Remitly, SimilarWeb, Shipper, Skillsoft, SoloLearn, Swiggy, and Udemy.

 

Hundreds of millions of people have made the platforms of its associates a part of their daily lives. For listed companies where we have an interest, please see: Tencent (www.tencent.com; SEHK:00700), Mail.ru (www.corp.mail.ru; LSE:MAIL), Trip.com Group Limited ("Trip.com") (NASDAQ:TCOM), and DeliveryHero (www.deliveryhero.com; Xetra:DHER).

 

Today, Prosus companies and associates help improve the lives of around a fifth of the world's population.

 

Prosus has a primary listing on Euronext Amsterdam (AEX:PRX) and secondary listings on the Johannesburg Stock Exchange (XJSE:PRX) and a2X Markets (PRX.AJ), and is majority owned by Naspers.

 

For more information, please visit www.prosus.com 

Disclaimer

The Share Repurchase is being conducted in accordance with Articles 5(1) and 5(3) of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation) and Articles 2 to 4 of Commission Delegated Regulation (EU) 2016/1052 supplementing the Market Abuse Regulation with regard to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation measures (the Delegated Regulation). This document is issued in connection with the disclosure and reporting obligation set out in Article 2(3), read with article 2(2), of the Delegated Regulation.

Consideration includes transaction costs.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFIVRRITIIL
Date   Source Headline
3rd Aug 201712:00 pmRNSCOMPETITION TRIBUNAL APPROVAL MEDIA24 NOVUS MERGER
2nd Aug 20172:00 pmRNSADR RATIO CHANGE
21st Jul 20173:11 pmRNSDirector/PDMR Shareholding
21st Jul 20171:00 pmRNSAnnual Financial Report
11th Jul 20174:56 pmRNSDirector/PDMR Shareholding
5th Jul 20174:50 pmRNSDirector/PDMR Shareholding
30th Jun 20177:30 amRNSBOND OFFERING BY MYRIAD - PRICING
23rd Jun 20172:00 pmRNSFinal Results
22nd Jun 20179:00 amRNSPOSSIBLE USD BOND OFFERING
14th Jun 20174:55 pmRNSTrading Statement
3rd Apr 201711:06 amRNSUPDATE ON MEDIA24 COMPETITION APPEAL COURT RULING
31st Mar 20173:29 pmRNSDirectorate Change
15th Mar 20172:06 pmRNSDirector/PDMR Shareholding
24th Feb 20172:30 pmRNSDirector/PDMR Shareholding
7th Feb 20172:21 pmRNSDirector/PDMR Shareholding
3rd Feb 20171:00 pmRNSNOTIFICATION s 122(3) OF THE CO ACT & s3.83(b) JSE
31st Jan 201712:00 pmRNSClosing of the ibibo/MakeMyTrip transaction
19th Jan 20172:01 pmRNSDirector/PDMR Shareholding
18th Jan 201711:30 amRNSClosing of the Allegro transaction
18th Jan 20177:14 amRNSNOTIFICATION IN TERMS OF S122(3) SA CO ACT
4th Jan 20172:30 pmRNSDirector/PDMR Shareholding
19th Dec 20163:00 pmRNSDirector/PDMR Shareholding
5th Dec 20163:30 pmRNSDirector/PDMR Shareholding
25th Nov 20162:00 pmRNSHalf-year Report
18th Nov 201612:20 pmRNSTrading Statement
18th Oct 20162:45 pmRNSMakeMyTrip Limited and Ibibo group to combine
14th Oct 20163:00 pmRNSDisposal
31st Aug 20164:30 pmRNSDirector/PDMR Shareholding
26th Aug 20164:00 pmRNSAGM Statement
22nd Jul 20162:30 pmRNSNotice of AGM
14th Jul 20164:09 pmRNSDirector/PDMR Shareholding
6th Jul 20164:01 pmRNSDirector/PDMR Shareholding
24th Jun 20165:00 pmRNSFinal Results
15th Jun 20162:00 pmRNSTrading Statement
13th Jun 20163:00 pmRNSNotice in terms of S122 of SA Companies Act
18th Apr 20164:00 pmRNSChange in reporting currency
31st Mar 20164:00 pmRNSDirector/PDMR Shareholding
31st Mar 20164:00 pmRNSDirector/PDMR Shareholding
15th Mar 20166:03 pmRNSADR ratio change and distribution
10th Mar 201612:31 pmRNSDirector/PDMR Shareholding
24th Feb 20163:12 pmRNSNOTIFICATION IN TERMS OF S122(3) OF THE CO ACT
29th Jan 20162:59 pmRNSDirectorate Change
26th Jan 20163:09 pmRNSDirector/PDMR Shareholding
26th Jan 201612:34 pmRNSDirector/PDMR Shareholding
20th Jan 20161:58 pmRNSCorrection to S122 notification just released
20th Jan 20161:36 pmRNSS122 of the SA Companies Act notification
30th Dec 20153:05 pmRNSDirector/PDMR Shareholding
29th Dec 20157:15 amRNSDirector/PDMR Shareholding
24th Dec 201510:05 amRNSDirector/PDMR Shareholding
18th Dec 20153:05 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.